| Patents for A61K 45 - Medicinal preparations containing active ingredients not provided for in groups (115,020) |
|---|
| 08/26/2010 | US20100216713 Novel compositions and methods in cancer associated with altered expression of prlr |
| 08/26/2010 | US20100216692 Acidic Insulin Preparations Having Improved Stability |
| 08/26/2010 | US20100215714 Treatment of stroke and other acute neural degenerative disorders using postpartum-derived cells |
| 08/26/2010 | US20100215576 Diagnosis and treatment of neuroectodermal tumors |
| 08/26/2010 | DE102009010489A1 Dissolving pathogenic body parts e.g. tumors, debris or parasites, comprises directly injecting once and/or many times and/or cell-dissolving substance (e.g. acid) into cells or cell complexes to be removed (e.g. tumor) using e.g. catheter |
| 08/26/2010 | DE102009008919A1 Behandlungslösung für die Behandlung von Wunden, insbesondere für die liquide Wundbehandlung Treatment solution for the treatment of wounds, in particular for the liquid treatment of wounds |
| 08/25/2010 | EP2221301A1 Heteroaryloxy quinazoline derivative |
| 08/25/2010 | EP2221054A1 CDK inhibitors for lowering intraocular pressure |
| 08/25/2010 | EP2221053A1 Pharmaceutical composition comprising protein methyltransferase I inhibitors and its use for treating tumour diseases |
| 08/25/2010 | EP2221047A1 Reverse-micellar delivery system for controlled transportation and enhanced absorption of agents |
| 08/25/2010 | EP2219695A2 Microsphere-based materials with predefined 3d spatial and temporal control of biomaterials, porosity and/or bioactive signals |
| 08/25/2010 | EP2219664A1 Methods for treating obesity and obesity related diseases and disorders |
| 08/25/2010 | EP2219627A2 Use of immunomodulatory compounds for the treatment of disorders associated with endothelial dysfunction |
| 08/25/2010 | EP2219619A1 Disulfide chemotherapeutic agents and methods of use thereof |
| 08/25/2010 | EP2219450A1 Alleviating neuropathic pain with eets and seh inhibitors |
| 08/25/2010 | EP1541161B1 Tablet composition containing chinese orthodox medicine extract and process for producing the same |
| 08/25/2010 | EP1517892B1 Ring-substituted diphenyl azetidinones, method for the production thereof, medicaments containing said compounds, and use thereof |
| 08/25/2010 | EP1482791B1 Antimicrobial therapeutic compositions and methods of use |
| 08/25/2010 | EP1480627B1 Methods of reducing angiogenesis |
| 08/25/2010 | EP1404367B1 Use of polyclonal anti-hiv goat serum as a therapeutic agent |
| 08/25/2010 | EP1133294B1 Compositions and methods for the treatment of alzheimer's disease, central nervous system injury, and inflammatory diseases |
| 08/25/2010 | EP0883403B1 Method for treating sexual dysfunctions |
| 08/25/2010 | CN1977972B Anti tumour drug oral colon targeting preparation and its preparing method |
| 08/25/2010 | CN1780627B Combinations for the treatment of diseases involving cell proliferation, migration or apoptosis of myeloma cells, or angiogenesis |
| 08/25/2010 | CN1665524B Use of alanyl-aminopeptidase inhibitors and pharmaceutical compositions containing said inhibitors |
| 08/25/2010 | CN101815534A methods and compositions for treating pulmonary hypertension and related diseases and disorders |
| 08/25/2010 | CN101815533A Combination therapy for the treatment of HCV infection |
| 08/25/2010 | CN101815532A Remedy for graft-versus-host disease comprising interleukin-6 receptor inhibitor as the active ingredient |
| 08/25/2010 | CN101812133A Receptor, the use thereof, and mouse antibodies |
| 08/25/2010 | CN101812118A Specific binding agents of human angiopoietin-2 |
| 08/25/2010 | CN101810861A Liquid preparation for preventing and curing mucous membrane and skin inflammation |
| 08/25/2010 | CN101810860A Medicinal composition having tumor-resistant synergy |
| 08/25/2010 | CN101810859A Medical composition containing aniline derivative |
| 08/25/2010 | CN101810613A Prevention and cure method for ectoparasite and compounds thereof |
| 08/25/2010 | CN101810592A Pharmaceutical preparation comprising an active dispersed on a matrix |
| 08/25/2010 | CN101810583A HIV (Human Immunodeficiency Virus) fusion inhibitor slow-release microsphere |
| 08/25/2010 | CN101810578A External aerosol for curing cold |
| 08/25/2010 | CN101810547A Fast dissolving orally consumable films |
| 08/25/2010 | CN101138558B Pentamidine and death domain receptor ligand united application |
| 08/25/2010 | CN101002947B Target medicine used for treating bacteriosis, and its preparing method |
| 08/24/2010 | US7781566 Peptides, mimetics and antibodies of erbB, TNF, and IgSF receptors; for preventing, treating, and diagnosing mammalian cancer tumors |
| 08/24/2010 | US7781470 Aminodicarboxylic acid derivatives having pharmaceutical properties |
| 08/24/2010 | US7781447 O-methylated rapamycin derivatives for alleviation and inhibition of lymphoproliferative disorders |
| 08/24/2010 | US7781444 For local application to anus, of alpha-adrenergic blocker, nitric oxide synthase inhibitor, prostaglandin F2 alpha , dopamine, morphine, beta -blockers, and 5-hydroxytryptamine |
| 08/24/2010 | US7781429 solubilizing a nonsteroidal antiinflammatory drug (NSAID) such as diclofenac by combining with at least two of camphor, menthol and thymol |
| 08/24/2010 | US7781393 Methods for inhibiting tumor cell growth |
| 08/24/2010 | US7781175 Modulators for to a G protein-coupled receptor protein using the receptor protein and a cholesterol metabolism-related substance; kits; signal transduction modulators |
| 08/24/2010 | US7781161 Detection cancer; controlling gene expression; detection hybrids |
| 08/24/2010 | US7780993 Therapeutic transplantation using developing, human or porcine, renal or hepatic, grafts |
| 08/24/2010 | US7780970 comprising a live Lactobacillus, an enzyme (glycosyl transferase enzyme, fructosyl transferase enzyme or glucan sucrase ) produced by the micro-organism and an exopolysaccharide (EPS) produced by the activity of the enzyme; food |
| 08/24/2010 | US7780959 Feline granulocyte macrophage colony stimulating factor nucleic acid molecules |
| 08/24/2010 | CA2548457C Coordination complex of diaminocyclohexaneplatinum(ii) with block copolymer containing poly(carboxylic acid) segment and antitumor agent comprising the same |
| 08/24/2010 | CA2507749C Methods and materials for preparation of modified antibody variable domains and therapeutic uses thereof |
| 08/24/2010 | CA2462510C Wipe formulation |
| 08/24/2010 | CA2445940C Prevention of epithelial cancer |
| 08/24/2010 | CA2445386C Hypotensive lipid (prostaglandin derivatives) and timolol compositions and methods of using same |
| 08/24/2010 | CA2436808C Liquid antimicrobial compositions |
| 08/24/2010 | CA2356189C Substance for obtaining highly effective tumor medications as well as a process |
| 08/24/2010 | CA2348493C Textured and porous silicone rubber |
| 08/24/2010 | CA2273821C Detection and modulation of the iaps and naip for the diagnosis and treatment of proliferative disease |
| 08/24/2010 | CA2213560C Pharmaceutical compositions for controlled release of soluble receptors |
| 08/19/2010 | WO2010093789A2 Combinational compositions and methods for treatment of cancer |
| 08/19/2010 | WO2010093243A1 Use of a combination of diazoxide and metformin for treating obesity or obesity related disorders |
| 08/19/2010 | WO2010092974A1 Brain tumor stem cell differentiation promoter, and therapeutic agent for brain tumor |
| 08/19/2010 | WO2010092317A1 Nmnat2 modulator |
| 08/19/2010 | WO2010092312A1 Combination of avermectins or mylbemycins with adrenergic receptors for treating or preventing skin diseases |
| 08/19/2010 | WO2010092163A2 Antidiabetic medications |
| 08/19/2010 | WO2010092124A1 Pharmaceutical composition comprising linagliptin and optionally a sglt2 inhibitor, and uses thereof |
| 08/19/2010 | WO2010091661A1 Treatment solution for treating wounds, in particular for liquid wound treatment |
| 08/19/2010 | WO2010075347A3 Treating hypertension with at least one angiotensin ii receptor blocker and chlorthalidone |
| 08/19/2010 | WO2010054858A3 Polyvinylpyrrolidone as a therapeutically active compound for the treatment and prevention of diseases involving bacterial, viral and fungal pathogens |
| 08/19/2010 | WO2010031825A3 Methods and compositions for the treatment of cancer |
| 08/19/2010 | WO2010026596A3 Compositions comprising polyhydroxyltate fatty alcohol derivatives and the therapeutic uses |
| 08/19/2010 | US20100212033 Novel ubiquitin lifases as therapeutic tragets |
| 08/19/2010 | US20100210714 Her-2/neu DNA Vaccine Having Anti-Cancer Activity |
| 08/19/2010 | US20100210583 Novel antifolate combination therapies |
| 08/19/2010 | US20100210552 Human glucagon-like peptide-1 mimics and their use in the treatment of diabetes and related conditions |
| 08/19/2010 | US20100209958 Method of treating arthritis and promoting growth of articular chondrocytes |
| 08/19/2010 | US20100209923 Probe for diagnosis of marfan syndrome and a method for screening using the probe |
| 08/19/2010 | US20100209529 Pharmacologic-functioning water and usage of the same |
| 08/19/2010 | US20100209514 Method of treating pain by administering 24 hour oral oploid formulations exhibiting rapid rate of initial rise of plasma drug level |
| 08/19/2010 | US20100209507 Methods of diagnosing and treating small intestinal bacterial overgrowth (sibo) and sibo-related conditions |
| 08/19/2010 | US20100209430 Method for treating erectile dysfunction |
| 08/19/2010 | US20100209408 Remodeling of Tissues and Organs |
| 08/19/2010 | US20100209406 Bacillus strains and methods for reducing e. coli disease and enhancing performance |
| 08/19/2010 | US20100209401 Use of SDF-1 to Improve Ischemic Myocardial Function |
| 08/19/2010 | US20100209351 Method of treating pain by administering 24 hour oral opioid formulations exhibiting rapid rate of initial rise of plasma drug level |
| 08/19/2010 | DE102009009245A1 Composition useful for prevention and treatment of viral infections, preferably influenza, conjunctivitis or cervicitis and secondary infections that are associated with it, comprises an agglutination inhibitor |
| 08/19/2010 | DE102009008851A1 Transdermal system, useful for treating multiple sclerosis and Crohn's disease, comprises an immunomodulator comprising e.g. quinoline, active agent impermeable protective layer, active agent reservoir and a carrier |
| 08/19/2010 | DE102009000854A1 Osteopontin-receptor-ligand for binding osteopontin receptors of podocytes of the renal corpuscles, useful for treating chronic renal failure |
| 08/19/2010 | CA2752437A1 Antidiabetic medications |
| 08/19/2010 | CA2752434A1 Pharmaceutical composition comprising linagliptin and a sglt2 inhibitor |
| 08/19/2010 | CA2752232A1 Combinational compositions and methods for treatment of cancer |
| 08/19/2010 | CA2751543A1 Combination of avermectins or mylbemycins with adrenergic receptors for treating or preventing skin diseases |
| 08/18/2010 | EP2219031A1 Use of leptin for treating human lipoatrophy and method of determining predisposition to said treatment |
| 08/18/2010 | EP2218735A1 Diagnostic and therapeutic use of Kremen 1 and 2, inhibitors of the canonical Wnt-signaltransduction |
| 08/18/2010 | EP2218733A1 Compounds and methods for treatment and diagnosis of chlamydial infection |
| 08/18/2010 | EP2218462A1 Pharmaceutical preparation for the treatment of depressive pathologies, comprising a protein with a high tryptophan/LNAAs (Large Neutral Amino Acids) ratio |
| 08/18/2010 | EP2217730A1 Methods for assaying mc1r variants and mitochondrial markers in skin samples |
| 08/18/2010 | EP2217275A2 Pharmaceutical compositon for cleansing of the bowel |